Back to Gene
MYH7 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

MYH7 gene

The MYH7 gene provides instructions for making the myosin heavy chain-7 protein, which is essential for cardiac and skeletal muscle contraction.

Normal Function

The MYH7 gene provides instructions for making a protein known as myosin heavy chain-7. This protein is found in heart (cardiac) muscle and in certain skeletal muscles, which are the muscles used for movement. Specifically, myosin heavy chain-7 is found in type I skeletal muscle fibers, also known as slow-twitch fibers. These fibers are the primary component of skeletal muscles that do not tire easily, such as the muscles involved in maintaining posture.

Myosin heavy chain-7 helps generate the mechanical force needed for muscles to contract. It combines with other proteins to form the thick filaments found within structures called sarcomeres. Sarcomeres are the basic units of muscle contraction, composed of overlapping thick and thin protein filaments. These filaments undergo cycles of attachment and release, allowing the thin filaments to slide past the thick filaments. These movements shorten the sarcomere, causing the muscle to contract. Regular contractions of cardiac muscle pump blood to the rest of the body, while the coordinated contraction and relaxation of skeletal muscles allow the body to move.

Health Conditions Related to Genetic Changes

Laing distal myopathy

Pathogenic variants in the MYH7 gene can cause Laing distal myopathy, a condition characterized by muscle weakness that worsens over time. The weakness typically affects the ankles and toes first but may eventually spread to the hands, fingers, face, hips, and shoulders. Some affected individuals develop dilated cardiomyopathy, a condition in which the cardiac muscle becomes thin and enlarged.

Myosin storage myopathy

Pathogenic variants in the MYH7 gene can cause myosin storage myopathy, which leads to muscle weakness that can worsen slowly over time. These variants cause cells to produce a version of myosin heavy chain-7 that does not function properly. The altered proteins accumulate within skeletal muscle fibers, forming protein clumps that can be seen during a muscle biopsy.

Nonsyndromic hypertrophic cardiomyopathy

Pathogenic variants in the MYH7 gene are a common cause of nonsyndromic hypertrophic cardiomyopathy, a condition characterized by the thickening (hypertrophy) of the cardiac muscle. Most of these variants lead to the substitution of one amino acid for another in the myosin heavy chain-7 protein, likely resulting in protein dysfunction.

Other Related Conditions

  • Congenital fiber-type disproportion
  • Familial restrictive cardiomyopathy
  • Nonsyndromic dilated cardiomyopathy

Frequently Asked Questions

You might notice gradual weakness in the ankles or toes, difficulty walking or climbing stairs, or a feeling of fatigue that worsens with activity. In heart‑related cases, symptoms can include shortness of breath, swelling in the legs, or an irregular heartbeat. If any of these appear, seek medical evaluation promptly. How is a MYH7 mutation confirmed, and what does the test involve?::A DNA test from a blood sample is used. The lab sequences the MYH7 gene to look for pathogenic variants. The test is usually part of a broader panel for cardiomyopathy or muscular dystrophy. Results are typically available in 2–4 weeks. If I have a MYH7 mutation, can I still exercise safely?::Moderate, low‑impact activities (walking, swimming, cycling) are generally safe, but high‑intensity or resistance training may worsen muscle weakness or strain the heart. Discuss an individualized exercise plan with a cardiologist or physiotherapist familiar with MYH7 disorders. What options exist for treating the heart complications associated with MYH7 mutations?::Treatment focuses on managing dilated cardiomyopathy: medications such as beta‑blockers, ACE inhibitors, or ARBs; diuretics for fluid buildup; and, in severe cases, implantable devices (ICD) or heart transplantation. Regular cardiac monitoring is essential.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA